These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 12768307

  • 1. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M, Predd H, Underwood R, Cook P.
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [Abstract] [Full Text] [Related]

  • 2. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T.
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [Abstract] [Full Text] [Related]

  • 3. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation.
    De Potter IY, Poumay Y, Squillace KA, Pittelkow MR.
    Exp Cell Res; 2001 Dec 10; 271(2):315-28. PubMed ID: 11716544
    [Abstract] [Full Text] [Related]

  • 4. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E, Calvo JC.
    J Cell Biochem; 2003 Oct 15; 90(3):561-72. PubMed ID: 14523990
    [Abstract] [Full Text] [Related]

  • 5. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W, Rosenberg MP, DiGiovanni J.
    Oncogene; 1997 Mar 27; 14(12):1435-44. PubMed ID: 9136987
    [Abstract] [Full Text] [Related]

  • 6. Decreased high-affinity epidermal growth factor receptors in psoriatic epidermis.
    Urano Y, Ikeuchi T, Fujimoto A, Asano T, Arase S, Shigemi F, Takeda K.
    Tokushima J Exp Med; 1989 Dec 27; 36(3-4):53-8. PubMed ID: 2636999
    [Abstract] [Full Text] [Related]

  • 7. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S, Ostman A, Rollman O.
    Arch Dermatol Res; 2008 Oct 27; 300(9):505-16. PubMed ID: 18446355
    [Abstract] [Full Text] [Related]

  • 8. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.
    Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG, Hynes NE.
    Cancer Res; 1997 Sep 01; 57(17):3804-11. PubMed ID: 9288791
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH.
    EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020
    [Abstract] [Full Text] [Related]

  • 10. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
    Borer JG, Park JM, Atala A, Nguyen HT, Adam RM, Retik AB, Freeman MR.
    Lab Invest; 1999 Nov 15; 79(11):1335-45. PubMed ID: 10576204
    [Abstract] [Full Text] [Related]

  • 11. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.
    Oncogene; 2000 Aug 31; 19(37):4243-54. PubMed ID: 10980598
    [Abstract] [Full Text] [Related]

  • 12. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y.
    Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
    Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC.
    J Cell Physiol; 1990 Jul 12; 144(1):144-50. PubMed ID: 1694857
    [Abstract] [Full Text] [Related]

  • 14. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX.
    Cancer Res; 1996 Mar 15; 56(6):1457-65. PubMed ID: 8640840
    [Abstract] [Full Text] [Related]

  • 15. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG, Kokeny KE, Dilts CA, Ethier SP.
    J Cell Physiol; 1995 Jun 15; 163(3):589-96. PubMed ID: 7775601
    [Abstract] [Full Text] [Related]

  • 16. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
    Gu J, Chen L, Shatos MA, Rios JD, Gulati A, Hodges RR, Dartt DA.
    Exp Eye Res; 2008 Feb 15; 86(2):322-34. PubMed ID: 18155194
    [Abstract] [Full Text] [Related]

  • 17. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
    Mincione G, Piccirelli A, Lazzereschi D, Salomon DS, Colletta G.
    J Cell Physiol; 1998 Aug 15; 176(2):383-91. PubMed ID: 9648926
    [Abstract] [Full Text] [Related]

  • 18. Expression of c-erbB receptors and ligands in human nasal epithelium.
    Polosa R, Prosperini G, Tomaselli V, Howarth PH, Holgate ST, Davies DE.
    J Allergy Clin Immunol; 2000 Dec 15; 106(6):1124-31. PubMed ID: 11112896
    [Abstract] [Full Text] [Related]

  • 19. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
    Graus-Porta D, Beerli RR, Daly JM, Hynes NE.
    EMBO J; 1997 Apr 01; 16(7):1647-55. PubMed ID: 9130710
    [Abstract] [Full Text] [Related]

  • 20. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW, Stonecypher MS, Carroll SL.
    Glia; 2003 Aug 01; 43(2):104-18. PubMed ID: 12838503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.